Cargando…

Relating CYP2B6 genotype and efavirenz resistance among post-partum women living with HIV with high viremia in Uganda: a nested cross-sectional study

BACKGROUND: We investigated the association between CYP2B6 polymorphisms and efavirenz drug resistance among women living with HIV who started on antiretroviral therapy during pregnancy and with high viremia during post-partum. METHODS: This was a cross-sectional study of women with viral loads grea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buzibye, Allan, Wools-Kaloustian, Kara, Olagunju, Adeniyi, Twinomuhwezi, Ellon, Yiannoutsos, Constantin, Owen, Andrew, Neary, Megan, Matovu, Joshua, Banturaki, Grace, Castelnuovo, Barbara, Lamorde, Mohammed, Khoo, Saye, Waitt, Catriona, Kiragga, Agnes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064798/ https://www.ncbi.nlm.nih.gov/pubmed/37004096 http://dx.doi.org/10.1186/s12981-023-00514-2

Ejemplares similares

Outcomes of retained and disengaged pregnant women living with HIV in Uganda
por: Kiragga, Agnes N., et al.
Publicado: (2021)

Plasma and breast milk pharmacokinetics of emtricitabine, tenofovir and lamivudine using dried blood and breast milk spots in nursing African mother–infant pairs
por: Waitt, Catriona, et al.
Publicado: (2018)

Development, validation and clinical application of a method for the simultaneous quantification of lamivudine, emtricitabine and tenofovir in dried blood and dried breast milk spots using LC–MS/MS
por: Waitt, Catriona, et al.
Publicado: (2017)

High prevalence and long duration of nervous system and psychiatric adverse drug reactions in Ugandan patients taking efavirenz 600 mg daily
por: Seden, Kay, et al.
Publicado: (2018)

A randomized comparison of health-related quality of life outcomes of dolutegravir versus efavirenz-based antiretroviral treatment initiated in the third trimester of pregnancy
por: Ochanda, Perez Nicholas, et al.
Publicado: (2022)

Associations between efavirenz concentrations, pharmacogenetics and neurocognitive performance in people living with HIV in Nigeria
por: Nwogu, Jacinta N., et al.
Publicado: (2021)

Validation and clinical application of a method to quantify efavirenz in cervicovaginal secretions from flocked swabs using liquid chromatography tandem mass spectrometry
por: Olagunju, Adeniyi, et al.
Publicado: (2022)

CD4 trajectory adjusting for dropout among HIV-positive patients receiving combination antiretroviral therapy in an East African HIV care centre
por: Kiragga, Agnes N, et al.
Publicado: (2014)

Comparison of efavirenz levels in blood and hair with pharmacy refills as measures of adherence and predictors of viral suppression among people living with HIV in Nigeria
por: Nwogu, Jacinta N., et al.
Publicado: (2022)

Effect of Food on the Steady-State Pharmacokinetics of Tenofovir and Emtricitabine plus Efavirenz in Ugandan Adults
por: Lamorde, Mohammed, et al.
Publicado: (2012)

Comparing the efficacy of efavirenz and boosted lopinavir using viremia copy-years
por: Lima, Viviane D, et al.
Publicado: (2014)

“It’s only fatness, it doesn’t kill”: a qualitative study on perceptions of weight gain from use of dolutegravir-based regimens in women living with HIV in Uganda
por: Alhassan, Yussif, et al.
Publicado: (2022)

‘I fear my partner will abandon me’: the intersection of late initiation of antenatal care in pregnancy and poor ART adherence among women living with HIV in South Africa and Uganda
por: Alhassan, Yussif, et al.
Publicado: (2022)

Contraceptive implant use duration is not associated with breakthrough pregnancy among women living with HIV and using efavirenz: a retrospective, longitudinal analysis
por: Stalter, Randy M., et al.
Publicado: (2022)

Patient experiences of switching from Efavirenz- to Dolutegravir-based antiretroviral therapy: a qualitative study in Uganda
por: Twimukye, Adelline, et al.
Publicado: (2021)

Efavirenz- but not nevirapine-based antiretroviral therapy decreases exposure to the levonorgestrel released from a sub-dermal contraceptive implant
por: Scarsi, Kimberly, et al.
Publicado: (2014)

Engendering health systems in response to national rollout of dolutegravir-based regimens among women of childbearing potential: a qualitative study with stakeholders in South Africa and Uganda
por: Alhassan, Yussif, et al.
Publicado: (2020)

Community acceptability of dolutegravir-based HIV treatment in women: a qualitative study in South Africa and Uganda
por: Alhassan, Yussif, et al.
Publicado: (2020)

Pharmacokinetics of maraviroc in plasma and breastmilk in a treatment-experienced perinatally HIV-1-infected woman
por: Feiterna-Sperling, Cornelia, et al.
Publicado: (2019)

A Lower Dose of Efavirenz Can Be Coadministered With Rifampicin and Isoniazid in Tuberculosis Patients
por: Kaboggoza, Julian P, et al.
Publicado: (2019)

Dosing antiretroviral medication when crossing time zones: a review
por: Lewis, Joseph M., et al.
Publicado: (2016)

The Utility of Efavirenz-based Prophylaxis Against HIV Infection. A Systems Pharmacological Analysis
por: Duwal, Sulav, et al.
Publicado: (2019)

The impact of genetic polymorphisms on the pharmacokinetics of efavirenz in African children
por: Bienczak, Andrzej, et al.
Publicado: (2016)

Use of a physiologically-based pharmacokinetic model to simulate artemether dose adjustment for overcoming the drug-drug interaction with efavirenz
por: Siccardi, Marco, et al.
Publicado: (2013)

Significant pharmacokinetic interactions between artemether/lumefantrine and efavirenz or nevirapine in HIV-infected Ugandan adults
por: Byakika-Kibwika, Pauline, et al.
Publicado: (2012)

Adolescent pregnancy at antiretroviral therapy (ART) initiation: a critical barrier to retention on ART
por: Nuwagaba‐Biribonwoha, Harriet, et al.
Publicado: (2018)

Is infant exposure to antiretroviral drugs during breastfeeding quantitatively important? A systematic review and meta-analysis of pharmacokinetic studies
por: Waitt, Catriona John, et al.
Publicado: (2015)

Drug Interactions between Dolutegravir and Artemether-Lumefantrine or Artesunate-Amodiaquine
por: Walimbwa, Stephen I., et al.
Publicado: (2019)

Using mechanistic physiologically-based pharmacokinetic models to assess prenatal drug exposure: Thalidomide versus efavirenz as case studies
por: Atoyebi, Shakir Adeyinka, et al.
Publicado: (2019)

Unintended Pregnancies Observed With Combined Use of the Levonorgestrel Contraceptive Implant and Efavirenz-based Antiretroviral Therapy: A Three-Arm Pharmacokinetic Evaluation Over 48 Weeks
por: Scarsi, Kimberly K., et al.
Publicado: (2016)

The Effect of HIV Treatment Interruption on Subsequent Immunological Response
por: Thomadakis, Christos, et al.
Publicado: (2023)

Pharmacokinetics of antimalarial drugs used to treat uncomplicated malaria in breastfeeding mother-infant pairs: An observational pharmacokinetic study
por: Nakijoba, Ritah, et al.
Publicado: (2023)

Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study
por: Dixon, Brian E., et al.
Publicado: (2020)

Association of Health Status and Nicotine Consumption with SARS-CoV-2 positivity rates
por: Duszynski, Thomas J., et al.
Publicado: (2021)

Clinical Outcomes After Viremia Among People Receiving Dolutegravir vs Efavirenz-Based First-line Antiretroviral Therapy in South Africa
por: Asare, Kwabena, et al.
Publicado: (2023)

Investigation of Efavirenz Discontinuation in Multi-ethnic Populations of HIV-positive Individuals by Genetic Analysis
por: Cummins, Nathan W., et al.
Publicado: (2015)

Alternative antiretroviral monitoring strategies for HIV-infected patients in east Africa: opportunities to save more lives?
por: Braithwaite, R Scott, et al.
Publicado: (2011)

Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study
por: Dixon, Brian E., et al.
Publicado: (2021)

Comparison of Methods for Correction of Mortality Estimates for Loss to Follow-Up after ART Initiation: A Case of the Infectious Diseases Institute, Uganda
por: Kiragga, Agnes N., et al.
Publicado: (2013)

A qualitative study of the barriers and enhancers to retention in care for pregnant and postpartum women living with HIV
por: Humphrey, John, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mt78hc0esn5n50p5v0t3qt1i1j